• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Incyte Corporation (INCY)

    -NasdaqGS
    119.93 Up 6.08(5.34%) Aug 28, 4:00PM EDT
    |After Hours : 120.44 Up 0.51 (0.43%) Aug 28, 7:56PM EDT
    Add to Portfolio
    Prev Close:113.85
    Open:113.15
    Bid:120.20 x 100
    Ask:121.00 x 100
    1y Target Est:125.00
    Beta:-0.061918
    Earnings Date:Oct 28 - Nov 2 (Est.)
    Day's Range:112.13 - 120.00
    52wk Range:43.86 - 121.70
    Volume:1,816,063
    Avg Vol (3m):1,108,380
    Market Cap:21.65B
    P/E (ttm):1,557.53
    EPS (ttm):0.08
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INCYUp 5.34%21.65B
    CELGUp 0.81%98.06B
    AMGNUp 0.11%118.20B

    Key Statistics

    Forward P/E (1 yr):171.33
    P/S (ttm):31.89
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.13
    Quarterly EPS Est (Sep-15) :-0.06
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-12.53

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback